NL-OMON40545已完成不适用
A DOUBLE-BLINDED, PLACEBO-CONTROLLED, SINGLE DOSE AND MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND PROOF OF CONCEPT OF DM-199 IN HEALTHY SUBJECTS AND PATIENTS WITH TYPE 2 DIABETES MELLITUS - DM-199 SAD, MAD and POC study
DiaMedica Inc.0 个研究点目标入组 96 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 96
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age: Healthy subjects (Parts A and C): 18 - 65 years, inclusive
- •: Type 2 diabetes mellitus patients (Parts B and D): 18 - 75 years, inclusive ;Body Mass Index (BMI): Healthy subjects (Parts A and C): 18.0 - 30.0 kg/m2
- •: Type 2 diabetes mellitus patients (Parts B and D): 25.0 - 35.0 kg/m2 for Part B and 25.0 - 45.0 kg/m2 with a maximum body weight up to 165 kg for Part D.;Gender : Healthy males or females; for Part D females must be of non-childbearing potential (either surgically sterilized or at least 1 year post-menopausal)
排除标准
- •Suffering from : hepatitis B. cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of the study. In case of donating blood or significant loss of blood within 60 days of the start of drug dosing.
研究者
相似试验
进行中（未招募）
不适用
A study on the safety, tolerability and the effect of DM-199 on the body, a new agent for the treatment of Diabetes Mellitus Type 2, after single- and multiple dosing in healthy volunteers and Diabetes Mellitus Type 2 patients.Diabetes Mellitus type 2MedDRA version: 16.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2013-000225-30-NLDiaMedica USA Inc.
进行中（未招募）
不适用
A RANDOMISED, DOUBLE-BLIND, SINGLE-DOSE, TWO-WAY CROSSOVER STUDY TO ASSESS THE BRONCHODILATING PROPERTIES OF A NEW GENERIC DRY POWDER FORMOTEROL FORMULATION GIVEN FROM A NOVEL DRY POWDER INHALER COMPARED TO THE REFERENCE FORADIL® AEROLIZER® IN MODERATE TO SEVERE ADULT ASTHMATIC SUBJECTSThis study has been initianed to assess the bronchodilating properties of a new generic dry powder formoterol formulation given from a novel dry powder inhaler compared to the reference Foradil Aerolizer in moderate to severe adult asthmatic subjects.EUCTR2007-003872-20-HUaboratorios Liconsa S.A.72
进行中（未招募）
不适用
A DOUBLE-BLIND, DOSE-RANGE, PLACEBO CONTROLLED STUDYOF THE EFFECTS OF PST2238 VS. PLACEBO IN PATIENTSWITH STABLE, UNCOMPLICATED, ESSENTIAL HYPERTENSION.EUCTR2004-000415-26-ITSIGMA-TA440
已完成
不适用
A DOUBLE-BLIND, PLACEBO-CONTROLLED DOSE ESCALATION STUDY OF THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF A SUBCUTANEOUS DOSE OF SHK-186 IN HEALTHY SUBJECTSDisorder in which the body makes antibodies against bodys own proteins10003816NL-OMON36904Kineta One56
进行中（未招募）
不适用
ot applicableEUCTR2011-002665-38-GBAlmirall S.A.110